Oxford University Press, Nephrology Dialysis Transplantation, 1(26), p. 170-177, 2010
DOI: 10.1093/ndt/gfq371
Full text: Download
Background. A potential contribution of local activation of the renin–angiotensin system (RAS) to the pathogenesis of renal injury has been indicated by evidence for blood pressure-independent renoprotective effects of angiotensin II (AngII) receptor blockers (ARBs). The present study was performed to test the hypothesis that urinary angiotensinogen provides a specific index of intrarenal RAS status in patients with immunoglobulin A (IgA) nephropathy.